Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Adjuvant Therapy in Pancreatic Cancer

February 16th 2017

Considerations in Locally Advanced Pancreatic Cancer

February 16th 2017

Ongoing Neoadjuvant Clinical Trials in Pancreatic Cancer

February 16th 2017

Neoadjuvant Therapy in Locally Advanced Pancreatic Cancer

February 16th 2017

Advanced Pancreatic Cancer: Quality of Life Considerations

February 16th 2017

Sequencing Decisions in Advanced Pancreatic Cancer

February 16th 2017

Liposomal Irinotecan in Advanced Pancreatic Cancer

February 16th 2017

Frontline Decisions in Metastatic Pancreatic Cancer

February 16th 2017

Metastatic Pancreatic Cancer: Dosing Strategies in the Frontline Setting

February 16th 2017

Current Practice With Molecular Testing in Pancreatic Cancer

February 16th 2017

Multidisciplinary Care in Advanced Pancreatic Cancer

February 16th 2017

Nivolumab With Nab-paclitaxel, Gemcitabine Shows Promise in Pancreatic Cancer

February 16th 2017

The combination regimen of the PD-1 inhibitor nivolumab (Opdivo) plus nab-paclitaxel and gemcitabine was found to demonstrate encouraging clinical activity and low toxicity levels in patients with metastatic pancreatic cancer.

The Future of HCC Treatment

February 15th 2017

Evidence With Checkpoint Inhibition in HCC

February 15th 2017

Emerging Multikinase Inhibitors in HCC

February 15th 2017

Emerging c-MET Inhibitors in HCC

February 15th 2017

Current Understanding With Biomarkers in HCC

February 15th 2017

Underlying Cirrhosis in the Second-Line Setting of HCC

February 15th 2017

Incorporating Regorafenib in the HCC Treatment Landscape

February 15th 2017

Improving Survival in HCC

February 15th 2017